8 Skin cleansers, antiseptics

and desloughing agents

Skin cleansers, antiseptics and

desloughing agents

Skin cleansers and antiseptics

Soap or detergent is used with water to cleanse intact skin;

emollient preparations such as aqueous cream or

emulsifying ointment can be used in place of soap or

detergent for cleansing dry skin.

An antiseptic is used for skin that is infected or that is

susceptible to recurrent infection. Detergent preparations

containing chlorhexidine p. 1277 or povidone-iodine below,

which should be thoroughly rinsed off, are used. Emollients

may also contain antiseptics.

Antiseptics such as chlorhexidine or povidone-iodine are

used on intact skin before surgical procedures; their

antiseptic effect is enhanced by an alcoholic solvent.

Antiseptic solutions containing cetrimide can be used if a

detergent effect is also required.

Hydrogen peroxide p. 1278, an oxidising agent, can be

used in solutions of up to 6% for skin disinfection, such as

cleansing and deodorising wounds and ulcers. Hydrogen

peroxide is also available as a cream for superficial bacterial

skin infections.

For irrigating ulcers or wounds, lukewarm sterile sodium

chloride 0.9% solution is used, but tap water is often

appropriate.

Potassium permanganate below solution 1 in 10 000, a

mild antiseptic with astringent properties, can be used for

exudative eczematous areas; treatment should be stopped

when the skin becomes dry.

Desloughing agents

Alginate, hydrogel and hydrocolloid dressings are effective

at wound debridement. Sterile larvae (maggots) (available

from BioMonde) are also used for managing sloughing

wounds and are prescribable on the NHS.

Desloughing solutions and creams are of little clinical

value. Substances applied to an open area are easily

absorbed and perilesional skin is easily sensitised.

Gravitational dermatitis may be complicated by

superimposed contact sensitivity to substances such as

neomycin sulfate p. 1230 or lanolin.

ANTISEPTICS AND DISINFECTANTS

Potassium permanganate

l INDICATIONS AND DOSE

Cleansing and deodorising suppurating eczematous

reactions and wounds

▶ TO THE SKIN

▶ Adult: For wet dressings or baths, use approximately

0.01% (1 in 10 000) solution

l CAUTIONS Irritant to mucous membranes

l DIRECTIONS FOR ADMINISTRATION Potassium

permanganate 0.1% solution to be diluted 1 in 10 to

provide a 0.01% (1 in 10 000) solution. With potassium

permanganate tablets for solution, 1 tablet dissolved in

4 litres of water provides a 0.01% (1 in 10 000) solution.

l PATIENT AND CARER ADVICE Can stain clothing, skin and

nails (especially with prolonged use).

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug. Forms available

from special-order manufacturers include: liquid

Tablet for cutaneous solution

▶ Permitabs (Alliance Pharmaceuticals Ltd)

Potassium permanganate 400 mg Permitabs 400mg tablets for

cutaneous solution | 30 tablet £19.25 DT = £19.25

ANTISEPTICS AND DISINFECTANTS › ALCOHOL

DISINFECTANTS

Alcohol

(Industrial methylated spirit)

l INDICATIONS AND DOSE

Skin preparation before injection

▶ TO THE SKIN

▶ Child: Apply as required

▶ Adult: Apply as required

l CONTRA-INDICATIONS Neonates

l CAUTIONS Avoid broken skin . flammable . patients have

suffered severe burns when diathermy has been preceded

by application of alcoholic skin disinfectants

l SIDE-EFFECTS

Overdose Features of acute alcohol intoxication include

ataxia, dysarthria, nystagmus, and drowsiness, which may

progress to coma, with hypotension and acidosis.

For details on the management of poisoning,

see Alcohol, under Emergency treatment of poisoning

p. 1359.

l PRESCRIBING AND DISPENSING INFORMATION Industrial

methylated spirits defined by the BP as a mixture of 19

volumes of ethyl alcohol of an appropriate strength with 1

volume of approved wood naphtha.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Liquid

▶ Alcohol (Non-proprietary)

Industrial methylated spirit 70% | 600 ml £6.56–£7.01

ANTISEPTICS AND DISINFECTANTS › IODINE

PRODUCTS

Povidone-iodine

l INDICATIONS AND DOSE

Skin disinfection

▶ TO THE SKIN

▶ Child: (consult product literature)

▶ Adult: (consult product literature)

BETADINE ® DRY POWDER SPRAY

Skin disinfection, particularly minor wounds and

infections

▶ TO THE SKIN

▶ Adult: Not for use in serous cavities (consult product

literature)

VIDENE ® SOLUTION

Skin disinfection

▶ TO THE SKIN

▶ Child: Apply undiluted in pre-operative skin

disinfection and general antisepsis

▶ Adult: Apply undiluted in pre-operative skin

disinfection and general antisepsis

1276 Skin cleansers, antiseptics and desloughing agents BNF 78

Skin

13

VIDENE ® SURGICAL SCRUB ®

Skin disinfection

▶ TO THE SKIN

▶ Child: Use as a pre-operative scrub for hand and skin

disinfection

▶ Adult: Use as a pre-operative scrub for hand and skin

disinfection

VIDENE ® TINCTURE

Skin disinfection

▶ TO THE SKIN

▶ Adult: Apply undiluted in pre-operative skin

disinfection

l CONTRA-INDICATIONS Avoid regular use in patients with

thyroid disorders (in adults). concomitant use of lithium . corrected gestational age under 32 weeks . infants bodyweight under 1.5 kg .regular use in neonates

l CAUTIONS Broken skin . large open wounds

CAUTIONS, FURTHER INFORMATION

▶ Large open wounds The application of povidone–iodine to

large wounds or severe burns may produce systemic

adverse effects such as metabolic acidosis, hypernatraemia

and impairment of renal function.

VIDENE ® TINCTURE Procedures involving hot wire cautery

and diathermy

l SIDE-EFFECTS

▶ Rare or very rare Eye erythema . punctate keratitis

▶ Frequency not known Cytotoxicity . eye discolouration

l PREGNANCY Sufficient iodine may be absorbed to affect

the fetal thyroid in the second and third trimester.

l BREAST FEEDING Avoid regular or excessive use.

l RENAL IMPAIRMENT Avoid regular application to inflamed

or broken skin or mucosa.

l EFFECT ON LABORATORY TESTS May interfere with thyroid

function tests.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug. Forms available

from special-order manufacturers include: liquid

Spray

▶ Betadine (Aspire Pharma Ltd)

Povidone-Iodine 25 mg per 1 gram Betadine 2.5% dry powder spray

| 100 ml G £9.95 DT = £9.95

Liquid

CAUTIONARY AND ADVISORY LABELS 15 (Only for use with alcoholic

solutions)

▶ Videne (Ecolab Healthcare Division)

Povidone-Iodine 75 mg per 1 ml Videne 7.5% surgical scrub solution

| 500 ml p £7.97 DT = £7.97

Povidone-Iodine 100 mg per 1 ml Videne 10% antiseptic solution | 500 ml G £7.97 DT = £7.97

ANTISEPTICS AND DISINFECTANTS › OTHER

Chlorhexidine

l INDICATIONS AND DOSE

CEPTON ® LOTION

For skin disinfection in acne

▶ TO THE SKIN

▶ Child: (consult product literature)

▶ Adult: (consult product literature)

CEPTON ® SKIN WASH

For use as skin wash in acne

▶ TO THE SKIN

▶ Child: (consult product literature)

▶ Adult: (consult product literature)

HIBITANE ® PLUS 5% CONCENTRATE SOLUTION

General and pre-operative skin disinfection

▶ TO THE SKIN

▶ Child: (consult product literature)

HIBISCRUB ®

Pre-operative hand and skin disinfection | General hand

and skin disinfection

▶ TO THE SKIN

▶ Child: Use as alternative to soap (consult product

literature)

▶ Adult: Use as alternative to soap (consult product

literature)

HIBITANE OBSTETRIC ®

For use in obstetrics and gynaecology as an antiseptic and

lubricant

▶ TO THE SKIN

▶ Adult: To be applied to skin around vulva and

perineum and to hands of midwife or doctor

HIBI ® LIQUID HAND RUB+

Hand and skin disinfection

▶ TO THE SKIN

▶ Child: To be used undiluted (consult product literature)

▶ Adult: To be used undiluted (consult product

literature)

HYDREX ® SOLUTION

For pre-operative skin disinfection

▶ TO THE SKIN

▶ Child: (consult product literature)

▶ Adult: (consult product literature)

HYDREX ® SURGICAL SCRUB

For pre-operative hand and skin disinfection | General

hand disinfection

▶ TO THE SKIN

▶ Child: (consult product literature)

▶ Adult: (consult product literature)

UNISEPT ®

For cleansing and disinfecting wounds and burns and

swabbing in obstetrics

▶ TO THE SKIN

▶ Child: (consult product literature)

▶ Adult: (consult product literature)

IMPORTANT SAFETY INFORMATION

In preterm neonates, use sparingly, monitor for skin

reactions, and do not allow solution to pool—risk of

severe chemical burns.

l CONTRA-INDICATIONS Alcoholic solutions not suitable

before diathermy . not for use in body cavities

l CAUTIONS Avoid contact with brain . avoid contact with

eyes . avoid contact with meninges . avoid contact with

middle ear

l SIDE-EFFECTS Skin reactions

l DIRECTIONS FOR ADMINISTRATION

HIBITANE ® PLUS 5% CONCENTRATE SOLUTION For preoperative skin preparation, dilute 1 in 10 (0.5%) with

alcohol 70%. For general skin disinfection, dilute 1 in 100

(0.05%) with water. Alcoholic solutions not suitable for use

before diathermy or on neonatal skin.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Cream

▶ Hibitane Obstetric (Derma UK Ltd)

Chlorhexidine gluconate 10 mg per 1 gram Hibitane Obstetric 1%

cream | 250 ml G £16.95

BNF 78 Skin cleansers, antiseptics and desloughing agents 1277

Skin

13

Liquid

CAUTIONARY AND ADVISORY LABELS 15 (For ethanolic solutions (e.g.

ChloraPrep ® and Hydrex ® only)

EXCIPIENTS: May contain Fragrances

▶ Cepton (Boston Healthcare Ltd)

Chlorhexidine gluconate 10 mg per 1 ml Cepton 1% medicated skin

wash | 150 ml G £34.75 DT = £34.75

▶ HiBiTane Plus (Molnlycke Health Care Ltd)

Chlorhexidine gluconate 50 mg per 1 ml HiBiTane Plus 5%

concentrate solution | 5000 ml G £14.50 DT = £14.50

▶ Hibi (Molnlycke Health Care Ltd)

Chlorhexidine gluconate 5 mg per 1 ml HiBi Liquid Hand Rub+ 0.5%

solution | 500 ml G £5.25 DT = £5.25

▶ Hibiscrub (Molnlycke Health Care Ltd)

Chlorhexidine gluconate 40 mg per 1 ml HiBiScrub 4% solution | 125 ml G £1.50 | 250 ml G £4.25 DT = £4.25 | 500 ml G £5.25 DT = £5.25 | 5000 ml G £24.00 DT = £24.00

▶ Hydrex (Ecolab Healthcare Division)

Chlorhexidine gluconate 5 mg per 1 ml Hydrex pink chlorhexidine

gluconate 0.5% solution | 600 ml G £4.91 DT = £4.91

Hydrex clear chlorhexidine gluconate 0.5% solution | 600 ml G £4.91 DT = £4.91

Chlorhexidine gluconate 40 mg per 1 ml Hydrex 4% Surgical Scrub

| 250 ml G £4.47 DT = £4.25 | 500 ml G £4.96 DT = £5.25

▶ Sterets Unisept (Molnlycke Health Care Ltd)

Chlorhexidine gluconate 500 microgram per 1 ml Sterets Unisept

0.05% solution 25ml sachets | 25 sachet p £5.54 DT = £5.54

Sterets Unisept 0.05% solution 100ml sachets | 10 sachet p £6.83

DT = £6.83

Chlorhexidine gluconate with

isopropyl alcohol

The properties listed below are those particular to the

combination only. For the properties of the components

please consider, chlorhexidine p. 1277.

l INDICATIONS AND DOSE

Skin disinfection before invasive procedures

▶ TO THE SKIN

▶ Child 2 months–17 years: (consult product literature)

▶ Adult: (consult product literature)

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug. Forms available

from special-order manufacturers include: liquid

Liquid

CAUTIONARY AND ADVISORY LABELS 15

▶ ChloraPrep (CareFusion U.K. Ltd)

Chlorhexidine gluconate 20 mg per 1 ml, Isopropyl alcohol

700 ml per 1 litre ChloraPrep with Tint solution 10.5ml applicators | 25 applicator G £76.65 DT = £73.00

ChloraPrep with Tint solution 26ml applicators | 25 applicator G £170.75 DT = £162.50

ChloraPrep solution 3ml applicators | 25 applicator G £21.25 DT =

£21.25

ChloraPrep solution 1.5ml applicators | 20 applicator G £11.00 DT

= £11.00

ChloraPrep with Tint solution 3ml applicators | 25 applicator G £22.31 DT = £21.25

ChloraPrep solution 0.67ml applicators | 200 applicator G £60.00

DT = £60.00

ChloraPrep solution 10.5ml applicators | 25 applicator G £73.00

DT = £73.00

ChloraPrep solution 26ml applicators | 25 applicator G £162.50

DT = £162.50

Chlorhexidine with cetrimide

The properties listed below are those particular to the

combination only. For the properties of the components

please consider, chlorhexidine p. 1277.

l INDICATIONS AND DOSE

Skin disinfection such as wound cleansing and obstetrics

▶ TO THE SKIN

▶ Child: To be used undiluted

▶ Adult: To be used undiluted

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Cream

▶ Chlorhexidine with cetrimide (Non-proprietary)

Chlorhexidine gluconate 1 mg per 1 gram, Cetrimide 5 mg per

1 gram Savlon antiseptic cream | 15 gram G £0.90 |

30 gram G £1.19 | 60 gram G £1.91 | 100 gram G £2.78

Irrigation solution

▶ Chlorhexidine with cetrimide (Non-proprietary)

Chlorhexidine acetate 150 microgram per 1 ml, Cetrimide 1.5 mg

per 1 ml Chlorhexidine acetate 0.015% / Cetrimide 0.15% irrigation

solution 1litre bottles | 1 bottle p s

Liquid

▶ Sterets Tisept (Molnlycke Health Care Ltd)

Chlorhexidine gluconate 150 microgram per 1 ml, Cetrimide

1.5 mg per 1 ml Sterets Tisept solution 25ml sachets | 25 sachet p

£5.33 DT = £5.33

Sterets Tisept solution 100ml sachets | 10 sachet p £6.85 DT = £6.85

Diethyl phthalate with methyl

salicylate

l INDICATIONS AND DOSE

Skin preparation before injection

▶ TO THE SKIN

▶ Adult: Apply to the area to be disinfected

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Liquid

CAUTIONARY AND ADVISORY LABELS 15

▶ Diethyl phthalate with methyl salicylate (Non-proprietary)

Methyl salicylate 5 ml per 1 litre, Diethyl phthalate 20 ml per

1 litre, Castor oil 25 ml per 1 litre, Industrial methylated spirit

950 ml per 1 litre Surgical spirit | 200 ml G £1.17 DT = £1.17 | 1000 ml G £3.95

Hydrogen peroxide

l DRUG ACTION Hydrogen peroxide is an oxidising agent.

l INDICATIONS AND DOSE

For skin disinfection, particularly cleansing and

deodorising wounds and ulcers

▶ TO THE SKIN

▶ Adult: Use 3% and 6% solutions (consult product

literature)

CRYSTACIDE ®

Superficial bacterial skin infection

▶ TO THE SKIN

▶ Child: Apply 2–3 times a day for up to 3 weeks

▶ Adult: Apply 2–3 times a day for up to 3 weeks

l UNLICENSED USE

▶ In children Licensed for use in children (age range not

specified by manufacturer).

l CONTRA-INDICATIONS Closed body cavities (in adults). deep wounds (in adults). large wounds (in adults). use as

1278 Skin cleansers, antiseptics and desloughing agents BNF 78

Skin

13

disinfection agent for surgical instruments (in adults). use

as enema (in adults). use during surgery (in adults)

l CAUTIONS Avoid on eyes . avoid on healthy skin . incompatible with products containing iodine or

potassium permanganate

l PRESCRIBING AND DISPENSING INFORMATION The BP

directs that when hydrogen peroxide is prescribed,

hydrogen peroxide solution 6% (20 vols) should be

dispensed.

Strong solutions of hydrogen peroxide which contain

27% (90 vols) and 30% (100 vols) are only for the

preparation of weaker solutions.

l HANDLING AND STORAGE Hydrogen peroxide bleaches

fabric.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug. Forms available

from special-order manufacturers include: liquid

Cream

EXCIPIENTS: May contain Edetic acid (edta), propylene glycol

▶ Crystacide (Reig Jofre UK Ltd)

Hydrogen peroxide 10 mg per 1 gram Crystacide 1% cream | 25 gram p £8.07 DT = £8.07 | 40 gram p £11.62

Liquid

▶ Hydrogen peroxide (Non-proprietary)

Hydrogen peroxide 60 mg per 1 ml Hydrogen peroxide 6% solution

| 200 ml G £0.67 | 500 ml G £3.02 | 2000 ml G £9.33

Hydrogen peroxide 90 mg per 1 ml Hydrogen peroxide 9% solution

| 200 ml G £0.72

Hydrogen peroxide 30 ml per 1 litre Hydrogen peroxide 3%

solution | 200 ml G £0.63

Proflavine

l INDICATIONS AND DOSE

Infected wounds | Infected burns

▶ TO THE SKIN

▶ Adult: (consult product literature)

l PATIENT AND CARER ADVICE Stains clothing.

l MEDICINAL FORMS Forms available from special-order

manufacturers include: liquid

Irrigation solutions

l IRRIGATION SOLUTIONS

Flowfusor sodium chloride 0.9% irrigation solution 120ml

bottles (Fresenius Kabi Ltd) Sodium chloride 9 mg per 1 ml 1 bottle . NHS indicative price = £1.71 . Drug Tariff (Part IXa)

Irriclens sodium chloride 0.9% irrigation solution aerosol

spray (ConvaTec Ltd) Sodium chloride 9 mg per 1 ml 240 ml . NHS

indicative price = £3.60 . Drug Tariff (Part IXa)

Normasol sodium chloride 0.9% irrigation solution 100ml

sachets (Molnlycke Health Care Ltd) Sodium chloride 9 mg per 1 ml

10 unit dose . NHS indicative price = £7.97 . Drug Tariff (Part IXa)

Normasol sodium chloride 0.9% irrigation solution 25ml

sachets (Molnlycke Health Care Ltd) Sodium chloride 9 mg per 1 ml

25 unit dose . NHS indicative price = £6.46 . Drug Tariff (Part IXa)

Sodium chloride 0.9% irrigation solution 20ml Clinipod unit

dose (Mayors Healthcare Ltd) Sodium chloride 9 mg per 1 ml 25 unit

dose . NHS indicative price = £4.80 . Drug Tariff (Part IXa)

Sodium chloride 0.9% irrigation solution 20ml ISO-POD unit

dose (St Georges Medical Ltd) Sodium chloride 9 mg per 1 ml 25 unit

dose . NHS indicative price = £4.95 . Drug Tariff (Part IXa)

Sodium chloride 0.9% irrigation solution 20ml Irripod unit

dose (C D Medical Ltd) Sodium chloride 9 mg per 1 ml 25 unit dose . NHS indicative price = £5.84 . Drug Tariff (Part IXa)

Sodium chloride 0.9% irrigation solution 20ml Sal-e Pods unit

dose (Ennogen Healthcare Ltd) Sodium chloride 9 mg per 1 ml 25 unit

dose . NHS indicative price = £4.80 . Drug Tariff (Part IXa)

Sodium chloride 0.9% irrigation solution 20ml Salipod unit

dose (Sai-Meds Ltd) Sodium chloride 9 mg per 1 ml 25 unit dose . NHS

indicative price = £4.99 . Drug Tariff (Part IXa)

Sodium chloride 0.9% irrigation solution 20ml Steripod unit

dose (Molnlycke Health Care Ltd) Sodium chloride 9 mg per 1 ml

25 unit dose . NHS indicative price = £7.96 . Drug Tariff (Part IXa)

Sodium chloride 0.9% irrigation solution 20ml Sterowash unit

dose (Steroplast Healthcare Ltd) Sodium chloride 9 mg per 1 ml

25 unit dose . NHS indicative price = £5.40 . Drug Tariff (Part IXa)

Sodium chloride 0.9% irrigation solution 20ml unit dose (Alissa

Healthcare Research Ltd) Sodium chloride 9 mg per 1 ml 25 unit dose . NHS indicative price = £7.36 . Drug Tariff (Part IXa)

Sodium chloride 0.9% irrigation solution 20ml unit dose (Bell,

Sons & Co (Druggists) Ltd) Sodium chloride 9 mg per 1 ml 25 unit dose . NHS indicative price = £6.76 . Drug Tariff (Part IXa)

Sodium chloride 0.9% irrigation solution 20ml unit dose (Crest

Medical Ltd) Sodium chloride 9 mg per 1 ml 25 unit dose . NHS

indicative price = £4.99 . Drug Tariff (Part IXa)

Sodium chloride 0.9% irrigation solution 20ml unit dose

(Mylan) Sodium chloride 9 mg per 1 ml 25 unit dose . NHS indicative

price = £5.50 . Drug Tariff (Part IXa)

Stericlens sodium chloride 0.9% irrigation solution aerosol

spray (C D Medical Ltd) Sodium chloride 9 mg per 1 ml 100 ml . NHS

indicative price = £2.07 . Drug Tariff (Part IXa)240 ml . NHS indicative

price = £3.15 . Drug Tariff (Part IXa)

8.1 Minor cuts and abrasions

Minor cuts and abrasions

Management

Many preparations traditionally used to manage minor

burns, and abrasions have fallen out of favour. Preparations

containing camphor and sulfonamides should be avoided.

Preparations such as magnesium sulfate paste are now rarely

used to treat carbuncles and boils as these are best treated

with antibiotics.

Cetrimide is used to treat minor cuts and abrasions and

proflavine above may be used to treat infected wounds or

burns, but its use has now been largely superseded by other

antispetics or suitable antibacterials. The effervescent effect

of hydrogen peroxide p. 1278 is used to clean minor cuts and

abrasions.

Flexible collodion (see castor oil with collodion and

colophony p. 1280) may be used to seal minor cuts and

wounds that have partially healed; skin tissue adhesives are

used similarly, and also for additional suture support.

ANTISEPTICS AND DISINFECTANTS › OTHER

Glycerol with magnesium sulfate and

phenol

l INDICATIONS AND DOSE

Treat carbuncles and boils

▶ TO THE SKIN

▶ Adult: To be applied under dressing

l DIRECTIONS FOR ADMINISTRATION Paste should be stirred

before use.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Paste

▶ Glycerol with magnesium sulfate and phenol (Non-proprietary)

Phenol 5 mg per 1 gram, Magnesium sulfate dried 450 mg per

1 gram, Glycerol 550 mg per 1 gram Magnesium sulfate paste | 25 gram G £0.76–£1.24 | 50 gram G £0.91–£2.48 DT = £2.48

BNF 78 Minor cuts and abrasions 1279

Skin

13

DERMATOLOGICAL DRUGS › COLLODIONS

Castor oil with collodion and

colophony

l INDICATIONS AND DOSE

Used to seal minor cuts and wounds that have partially

healed

▶ TO THE SKIN

▶ Child: (consult product literature)

▶ Adult: (consult product literature)

l ALLERGY AND CROSS-SENSITIVITY Contra-indicated if

patient has an allergy to colophony in elastic adhesive

plasters and tape.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Form unstated

▶ Castor oil with collodion and colophony (Non-proprietary)

Castor oil 25 mg per 1 ml, Colophony 25 mg per 1 ml, Collodion

methylated 950 microlitre per 1 ml Flexible collodion methylated

| 100 ml £13.81–£14.09 | 500 ml £29.47

Skin adhesives

l SKIN ADHESIVES

Derma+Flex skin adhesive (Chemence Ltd)

0.5 ml . NHS indicative price = £5.36 . Drug Tariff (Part IXa)

Dermabond ProPen skin adhesive (Ethicon Ltd)

0.5 ml . NHS indicative price = £19.46 . Drug Tariff (Part IXa)

Histoacryl L skin adhesive (B.Braun Medical Ltd)

0.5 ml . NHS indicative price = £6.72 . Drug Tariff (Part IXa)

Histoacryl skin adhesive (B.Braun Medical Ltd)

0.5 ml . NHS indicative price = £6.50 . Drug Tariff (Part IXa)

Indermil skin adhesive (Covidien (UK) Commercial Ltd)

0.5 gram . NHS indicative price = £6.50 . Drug Tariff (Part IXa)

LiquiBand flow control tissue adhesive (Advanced Medical

Solutions Ltd)

0.5 gram . NHS indicative price = £5.50 . Drug Tariff (Part IXa)

LiquiBand tissue adhesive (Advanced Medical Solutions Ltd)

0.5 gram . NHS indicative price = £5.50 . Drug Tariff (Part IXa)

9 Skin disfigurement

Camouflagers

Overview

Disfigurement of the skin can be very distressing to patients

and may have a marked psychological effect. In skilled

hands, or with experience, camouflage cosmetics can be very

effective in concealing scars and birthmarks. The

depigmented patches in vitiligo are also very disfiguring and

camouflage creams are of great cosmetic value.

Opaque cover foundation or cream is used to mask skin

pigment abnormalities; careful application using a

combination of dark- and light-coloured cover creams set

with powder helps to minimise the appearance of skin

deformities.

Borderline substances

The preparations marked ‘ACBS’ can be prescribed on the

NHS for postoperative scars and other deformities and as

adjunctive therapy in the relief of emotional disturbances

due to disfiguring skin disease, such as vitiligo.

Camouflages

l CAMOUFLAGES

Covermark classic foundation (Derma UK Ltd)

15 ml(ACBS) . NHS indicative price = £11.86

Covermark finishing powder (Derma UK Ltd)

25 gram(ACBS) . NHS indicative price = £11.86

Covermark removing cream (Derma UK Ltd)

200 ml . No NHS indicative price available

Deep Skin Cleanser (SkinKind Ltd)

100 ml . NHS indicative price = £19.50

Dermablend Dermasmooth Corrective Foundation (Vichy)

30 ml . No NHS indicative price available

Dermacolor Creme Effectiv (Kryolan UK Ltd)

50 ml . NHS indicative price = £5.73

Dermacolor body camouflage (Kryolan UK Ltd)

50 ml . NHS indicative price = £8.94

Dermacolor camouflage creme (Kryolan UK Ltd)

30 gram . NHS indicative price = £11.00

Dermacolor cleansing cream (Kryolan UK Ltd)

75 gram . No NHS indicative price available

Dermacolor fixing powder (Kryolan UK Ltd)

60 gram(ACBS) . NHS indicative price = £9.85

Keromask finishing powder (Bellava Ltd)

20 gram(ACBS) . NHS indicative price = £6.27

Keromask masking cream (Bellava Ltd)

15 ml(ACBS) . NHS indicative price = £6.27

Veil cleansing cream (Thomas Blake Cosmetic Creams Ltd)

50 gram . NHS indicative price = £2.45 | 100 gram . NHS indicative price =

£3.90

Veil cover cream (Thomas Blake Cosmetic Creams Ltd)

19 gram(ACBS) . NHS indicative price = £22.42 | 44 gram(ACBS) . NHS

indicative price = £33.35 | 70 gram(ACBS) . NHS indicative price = £42.10

Veil finishing powder (Thomas Blake Cosmetic Creams Ltd)

35 gram(ACBS) . NHS indicative price = £24.58

10 Sun protection and

photodamage

Sunscreen

Sunscreen preparations

Solar ultraviolet irradiation can be harmful to the skin. It is

responsible for disorders such as polymorphic light eruption,

solar urticaria, and it provokes the various cutaneous

porphyrias. It also provokes (or at least aggravates) skin

lesions of lupus erythematosus and may aggravate rosacea

and some other dermatoses. Certain drugs, such as

demeclocycline, phenothiazines, or amiodarone, can cause

photosensitivity. All these conditions (as well as sunburn)

may occur after relatively short periods of exposure to the

sun. Solar ultraviolet irradiation may provoke attacks of

recurrent herpes labialis (but it is not known whether the

effect of sunlight exposure is local or systemic).

The effects of exposure over longer periods include ageing

changes and more importantly the initiation of skin cancer.

Solar ultraviolet radiation is approximately 200–400 nm in

wavelength. The medium wavelengths (290–320 nm, known

as UVB) cause sunburn. The long wavelengths (320–400 nm,

known as UVA) are responsible for many photosensitivity

reactions and photodermatoses. Both UVA and UVB

contribute to long-term photodamage and to the changes

responsible for skin cancer and ageing.

Sunscreen preparations contain substances that protect

the skin against UVA and UVB radiation, but they are no

substitute for covering the skin and avoiding sunlight. The

sun protection factor (SPF, usually indicated in the

preparation title) provides guidance on the degree of

1280 Skin disfigurement BNF 78

Skin

13

protection offered against UVB; it indicates the multiples of

protection provided against burning, compared with

unprotected skin; for example, an SPF of 8 should enable a

person to remain 8 times longer in the sun without burning.

However, in practice, users do not apply sufficient sunscreen

product and the protection is lower than that found in

experimental studies.

Some manufacturers use a star rating system to indicate

the protection against UVA relative to protection against

UVB for sunscreen products. However, the usefulness of the

star rating system remains controversial. The EU

Commission (September 2006) has recommended that the

UVA protection factor for a sunscreen should be at least onethird of the sun protection factor (SPF); products that

achieve this requirement will be labelled with a UVA logo

alongside the SPF classification. Preparations that also

contain reflective substances, such as titanium dioxide,

provide the most effective protection against UVA.

Sunscreen preparations may rarely cause allergic

reactions.

For optimum photoprotection, sunscreen preparations

should be applied thickly and frequently (approximately

2 hourly). In photodermatoses, they should be used from

spring to autumn. As maximum protection from sunlight is

desirable, preparations with the highest SPF should be

prescribed.

Ingredient nomenclature in sunscreen

preparations

rINN INCI

amiloxate isoamyl p-methoxycinnamate

avobenzone butyl methoxydibenzoylmethane

bemotrizinol bis-ethylhexyloxyphenol

methoxyphenyl triazine

bisoctrizole methylene bis-benzotriazolyl

tetramethylbutylphenol

ecamsule terephthalylidene dicamphor

sulfonic acid

ensulizole phenylbenzimidazole sulfonic acid

enzacamene 4-methylbenzylidene camphor

octinoxate octyl (or ethylhexyl)

methoxycinnamate

octocrilene octocrylene

oxybenzone benzophenone-3

The European Commission Cosmetic Products Regulation (EC)

1223/2009 requires the use of INCI (International Nomenclature

of Cosmetic Ingredients) for cosmetics and sunscreens. This table

includes the rINN and the INCI synonym for the active ingredients

of sunscreen preparations in the BNF

Borderline substances

Anthelios ® XL SPF 50+ Melt-in cream; Sunsense ® Ultra;

Uvistat ® Lipscreen SPF 50; and Uvistat ® Suncream SPF 30

and 50 (see Borderline substances) are regarded as drugs

when prescribed for skin protection against ultraviolet

radiation in abnormal cutaneous photosensitivity.

Preparations with SPF less than 30 should not normally be

prescribed

Photodamage

Overview

Patients should be advised to use a high-SPF sunscreen and

to minimise exposure of the skin to direct sunlight or sun

lamps.

Topical treatments can be used for actinic keratosis. An

emollient may be sufficient for mild lesions. Diclofenac

sodium gel below is suitable for the treatment of superficial

lesions in mild disease. Fluorouracil cream p. 1282 is

effective against most types of non-hypertrophic actinic

keratosis; a solution containing fluorouracil with salicylic

acid p. 1282 is available for the treatment of low or

moderately thick hyperkeratotic actinic keratosis.

Imiquimod p. 1285 is used for lesions on the face and scalp

when cryotherapy or other topical treatments cannot be

used. Fluorouracil and imiquimod produce a more marked

inflammatory reaction than diclofenac sodium but lesions

resolve faster. A short course of ingenol mebutate p. 1282 is

licensed for the treatment of non-hypertrophic actinic

keratosis; response to treatment can usually be assessed

8 weeks after the course. Photodynamic therapy in

combination with methyl-5-aminolevulinate cream

(Metvix ®, available from Galderma) or 5-aminolaevulinic

acid gel (Ameluz ®, available from Spirit Healthcare) is used

in specialist centres for treating superficial and confluent,

non-hypertrophic actinic keratosis when other treatments

are inadequate or unsuitable; it is particularly suitable for

multiple lesions, for periorbital lesions, or for lesions located

at sites of poor healing.

Imiquimod or topical fluorouracil is used for treating

superficial basal cell carcinomas. Photodynamic therapy in

combination with methyl-5-aminolevulinate cream is used

in specialist centres for treating superficial, nodular basal

cell carcinomas when other treatments are unsuitable.

ANALGESICS › NON-STEROIDAL ANTIINFLAMMATORY DRUGS

Diclofenac sodium 22-Sep-2016

l INDICATIONS AND DOSE

SOLARAZE ®

Actinic keratosis

▶ TO THE SKIN

▶ Adult: Apply twice daily for 60–90 days, to be applied

thinly; maximum 8 g per day

l CAUTIONS Avoid contact with eyes . avoid contact with

inflamed or broken skin . avoid contact with mucous

membranes . not for use with occlusive dressings .topical

application of large amounts can result in systemic effects,

including hypersensitivity and asthma (renal disease has

also been reported)

l INTERACTIONS → Appendix 1: NSAIDs

l SIDE-EFFECTS

▶ Common or very common Conjunctivitis . muscle tone

increased . oedema .rash (discontinue). sensation

abnormal . skin reactions . skin ulcer

▶ Uncommon Abdominal pain . alopecia . diarrhoea . eye pain . haemorrhage . lacrimation disorder. nausea . seborrhoea

▶ Rare or very rare Acute kidney injury . asthma . hypersensitivity . photosensitivity reaction .rash pustular

▶ Frequency not known Hair colour changes

SIDE-EFFECTS, FURTHER INFORMATION Topical application

of large amounts of diclofenac can result in systemic

effects.

l ALLERGY AND CROSS-SENSITIVITY Contra-indicated in

patients with a history of hypersensitivity to aspirin or any

other NSAID—which includes those in whom attacks of

asthma, angioedema, urticaria or rhinitis have been

precipitated by aspirin or any other NSAID.

l PREGNANCY Patient packs for topical preparations carry a

warning to avoid during pregnancy.

l BREAST FEEDING Patient packs for topical preparations

carry a warning to avoid during breast-feeding.

BNF 78 Sun protection and photodamage 1281

Skin

13

l DIRECTIONS FOR ADMINISTRATION For topical

preparations, apply with gentle massage only.

l PATIENT AND CARER ADVICE For topical preparations,

patients and their carers should be advised to wash hands

immediately after use.

Photosensitivity Patients should be advised against

excessive exposure to sunlight of area treated in order to

avoid possibility of photosensitivity.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Gel

EXCIPIENTS: May contain Benzyl alcohol, fragrances, propylene glycol

▶ Solaraze (Almirall Ltd)

Diclofenac sodium 30 mg per 1 gram Solaraze 3% gel | 50 gram P £38.30 DT = £38.30 | 100 gram P £76.60

ANTINEOPLASTIC DRUGS › ANTIMETABOLITES

Fluorouracil 22-May-2019

l INDICATIONS AND DOSE

Superficial malignant and pre-malignant skin lesions

▶ TO THE SKIN USING CREAM

▶ Adult: Apply 1–2 times a day for 3–4 weeks (usual

duration of initial therapy), apply thinly to the affected

area, maximum area of skin 500 cm2 (e.g. 23 cm 6

23 cm) treated at one time, alternative regimens may

be used in some settings

l CAUTIONS Avoid contact with eyes and mucous

membranes . dihydropyrimidine dehydrogenase deficiency . do not apply to bleeding lesions

l INTERACTIONS → Appendix 1: fluorouracil

l SIDE-EFFECTS

▶ Common or very common Alopecia . diarrhoea . mucositis . nausea . neutropenia . skin reactions . stomatitis . thrombocytopenia . vomiting

▶ Uncommon Dizziness . headache

▶ Rare or very rare Abdominal pain . chills . diarrhoea

haemorrhagic . fever. leucocytosis . pancytopenia . skin

irritation (use a topical corticosteroid for severe

discomfort associated with inflammatory reactions). skin

ulcer

▶ Frequency not known Conjunctival irritation . excessive

tearing . keratitis .taste altered

l CONCEPTION AND CONTRACEPTION Contraceptive advice

required, see Pregnancy and reproductive function in

Cytotoxic drugs p. 888.

l PREGNANCY Manufacturers advise avoid (teratogenic).

l BREAST FEEDING Manufacturers advise avoid.

l HANDLING AND STORAGE Caution in handling—irritant to

tissues.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Cream

EXCIPIENTS: May contain Cetostearyl alcohol (including cetyl and

stearyl alcohol), hydroxybenzoates (parabens), polysorbates, propylene

glycol

▶ Efudix (Meda Pharmaceuticals Ltd)

Fluorouracil 50 mg per 1 gram Efudix 5% cream | 40 gram P £32.90 DT = £32.90

Fluorouracil with salicylic acid

The properties listed below are those particular to the

combination only. For the properties of the components

please consider, fluorouracil above, salicylic acid p. 1286.

l INDICATIONS AND DOSE

Low or moderately thick hyperkeratotic actinic keratosis

▶ TO THE SKIN

▶ Adult: Apply once daily for up to 12 weeks, reduced to

3 times a week if severe side effects occur and until

side-effects improve, to be applied to the affected area,

if treating area with thin epidermis, reduce frequency

of application and monitor response more often;

maximum area of skin treated at one time, 25 cm2 (e.g.

5 cm 6 5 cm)

l INTERACTIONS → Appendix 1: fluorouracil

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Cutaneous solution

CAUTIONARY AND ADVISORY LABELS 15

▶ Actikerall (Almirall Ltd)

Fluorouracil 5 mg/g, Salicylic acid 100 mg/g Actikerall 5mg/g /

100mg/g cutaneous solution | 25 ml P £38.30 DT = £38.30

PROTEIN KINASE C ACTIVATORS

Ingenol mebutate

l INDICATIONS AND DOSE

Actinic keratosis on face and scalp

▶ TO THE SKIN

▶ Adult: Apply once daily for 3 days, use the

150 microgram/g gel

Actinic keratosis on trunk and extremities

▶ TO THE SKIN

▶ Adult: Apply once daily for 2 days, use the

500 microgram/g gel

l CAUTIONS Avoid contact with broken skin . avoid contact

with eyes . avoid contact with inside of ears . avoid contact

with inside of nostrils . avoid contact with lips . avoid

occlusive dressings on treated area

l SIDE-EFFECTS

▶ Common or very common Headache . infection . local

reaction . oedema . pain . skin reactions

▶ Uncommon Paraesthesia . skin ulcer

l PREGNANCY Not absorbed from skin, but manufacturer

advises avoid.

l BREAST FEEDING Not absorbed from skin; ensure infant

does not come in contact with treated area for 6 hours

after application.

l DIRECTIONS FOR ADMINISTRATION One tube covers skin

area of 25 cm2

. Allow gel to dry on treatment area for

15 minutes. Avoid washing or touching the treated area for

6 hours after application; after this time, area may be

washed with mild soap and water. Avoid use immediately

after shower or less than 2 hours before bedtime.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Gel

CAUTIONARY AND ADVISORY LABELS 15

EXCIPIENTS: May contain Benzyl alcohol

▶ Picato (LEO Pharma)

Ingenol mebutate 150 microgram per 1 gram Picato

150micrograms/g gel | 1.41 gram P £65.00 DT = £65.00

Ingenol mebutate 500 microgram per 1 gram Picato

500micrograms/g gel | 0.94 gram P £65.00 DT = £65.00

1282 Sun protection and photodamage BNF 78

Skin

13

11 Superficial soft-tissue

injuries and superficial

thrombophlebitis

Topical circulatory preparations

Overview

These preparations are used to improve circulation in

conditions such as bruising, superficial thrombophlebitis,

chilblains and varicose veins but are of little value. Chilblains

are best managed by avoidance of exposure to cold; neither

systemic nor topical vasodilator therapy is established as

being effective.

HEPARINOIDS

Heparinoid

l INDICATIONS AND DOSE

Superficial thrombophlebitis | Bruising | Haematoma

▶ TO THE SKIN

▶ Adult: Apply up to 4 times a day

l CONTRA-INDICATIONS Should not be used on large areas of

skin, broken or sensitive skin, or mucous membranes

l LESS SUITABLE FOR PRESCRIBING Hirudoid ® is less

suitable for prescribing.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Cream

EXCIPIENTS: May contain Cetostearyl alcohol (including cetyl and

stearyl alcohol), hydroxybenzoates (parabens)

▶ Hirudoid (Genus Pharmaceuticals Ltd)

Heparinoid 3 mg per 1 gram Hirudoid 0.3% cream | 50 gram p

£3.99 DT = £3.99

Gel

EXCIPIENTS: May contain Fragrances, propylene glycol

▶ Hirudoid (Genus Pharmaceuticals Ltd)

Heparinoid 3 mg per 1 gram Hirudoid 0.3% gel | 50 gram p £3.99

DT = £3.99

12 Warts and calluses

Warts and calluses

Overview

Warts (verrucas) are caused by a human papillomavirus,

which most frequently affects the hands, feet (plantar warts),

and the anogenital region; treatment usually relies on local

tissue destruction. Warts may regress on their own and

treatment is required only if the warts are painful, unsightly,

persistent, or cause distress.

Preparations of salicylic acid p. 1286, formaldehyde

p. 1284, glutaraldehyde p. 1284 or silver nitrate p. 1285 are

available for purchase by the public; they are suitable for the

removal of warts on hands and feet. Salicylic acid is a useful

keratolytic which may be considered first-line; it is also

suitable for the removal of corns and calluses. Preparations of

salicylic acid in a collodion basis are available but some

patients may develop an allergy to colophony in the

formulation; collodion should be avoided in children allergic

to elastic adhesive plaster. Cryotherapy causes pain,

swelling, and blistering, and may be no more effective than

topical salicylic acid in the treatment of warts.

Anogenital warts

The treatment of anogenital warts (condylomata acuminata)

should be accompanied by screening for other sexually

transmitted infections. Podophyllotoxin p. 1284 (the major

active ingredient of podophyllum) may be used for soft, nonkeratinised external anogenital warts. Patients with a limited

number of external warts or keratinised lesions may be better

treated with cryotherapy or other forms of physical ablation.

Imiquimod cream p. 1285 is licensed for the treatment of

external anogenital warts; it may be used for both

keratinised and non-keratinised lesions. It is also licensed

for the treatment of superficial basal cell carcinoma and

actinic keratosis. Camellia sinensis ointment below is

licensed for the treatment of external anogenital warts.

Inosine pranobex p. 633 is licensed for adjunctive

treatment of genital warts but it has been superseded by

more effective drugs.

ANTINEOPLASTIC DRUGS › PLANT ALKALOIDS

Camellia sinensis 03-May-2017

l DRUG ACTION Camellia sinensis is an extract from green

tea leaves. The exact mechanism of action is not known;

non-clinical studies have shown inhibition of the growth

of activated keratinocytes, and anti-oxidative effects at the

site of application.

l INDICATIONS AND DOSE

Warts (external genital and perianal) in

immunocompetent patients

▶ TO THE LESION

▶ Adult: Apply up to 250 mg 3 times a day until complete

clearance of warts (maximum 16 weeks), do not exceed

treatment period even if new warts develop; maximum

750 mg per day

DOSE EQUIVALENCE AND CONVERSION

▶ 250 mg is equivalent to 0.5 cm of ointment.

l CAUTIONS Avoid broken skin . avoid contact with eyes . avoid contact with lips . avoid contact with mouth . avoid

contact with nostrils . avoid inflamed skin . uncircumcised

males (risk of phimosis). vulvar region

l SIDE-EFFECTS

▶ Uncommon Balanoposthitis . increased risk of infection . lymphatic abnormalities . necrosis . painful sexual

intercourse . phimosis . skin reactions . urinary disorders

▶ Frequency not known Urinary tract stenosis . vaginal

discharge

l CONCEPTION AND CONTRACEPTION Manufacturer advises

Catephen ® may weaken condoms and vaginal

diaphragms—alternative methods of contraception should

be considered.

l PREGNANCY Manufacturer advises avoid—toxicity in

animal studies.

l BREAST FEEDING Manufacturer advises risk to infant

cannot be excluded—no information available.

l HEPATIC IMPAIRMENT Manufacturer advises avoid in

severe impairment (limited information available).

l DIRECTIONS FOR ADMINISTRATION Manufacturer advises

apply to each wart, ensuring a thin layer is left on the wart.

It is not necessary to wash off the ointment from the area

before next application.

l PATIENT AND CARER ADVICE Manufacturer advises the

ointment should be washed off before sexual activity.

Manufacturer advises female patients using tampons

should insert tampon before applying the ointment.

l NATIONAL FUNDING/ACCESS DECISIONS

Scottish Medicines Consortium (SMC) decisions

The Scottish Medicines Consortium has advised (April 2016)

that camellia sinensis (green tea) leaf extract (Catephen ®)

BNF 78 Warts and calluses 1283

Skin

13

Comments

Search This Blog

Archive

Show more

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

علاقة البيبي بالفراولة بالالفا فيتو بروتين

التغيرات الخمس التي تحدث للجسم عند المشي

إحصائيات سنة 2020 | تعداد سكَان دول إفريقيا تنازليا :

ما هو الليمونير للأسنان ؟

ACUPAN 20 MG, Solution injectable

CELEPHI 200 MG, Gélule

الام الظهر

VOXCIB 200 MG, Gélule

ميبستان

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

Kana Brax Laberax

TRIPASS XR تري باس

PARANTAL 100 MG, Suppositoire بارانتال 100 مجم تحاميل

الكبد الدهني Fatty Liver

الم اسفل الظهر (الحاد) الذي يظهر بشكل مفاجئ bal-agrisi

SEDALGIC 37.5 MG / 325 MG, Comprimé pelliculé [P] سيدالجيك 37.5 مجم / 325 مجم ، قرص مغلف [P]

نمـو الدمـاغ والتطـور العقـلي لـدى الطفـل

CELEPHI 200 MG, Gélule

أخطر أنواع المخدرات فى العالم و الشرق الاوسط

Archive

Show more